St. Louis cancer drug startup Immunophotonics Inc. will pursue expansion of its lead drug candidate through a partnership with the...

Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. will be attending the SIO Annual Scientific Meeting January 26...

Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) are looking forward to attending Spectrum Conference, January...

Our networking is well underway with investors and potential strategic partners for the JPM 2024.  Attending the annual summit Lu...

Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a research collaboration with Johnson & Johnson...

Immunophotonics co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President attending the AngioDynamics International Life Symposium taking place...

Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be attending ESMO Conference, October 20 –...

Immunophotonics CEO Lu Alleruzzo will be participating at the ThinkEquity Conference in Mandarin Oriental, New York on October 19th. Check...

Immunophotonics Co-founder, CIO, and President Tomas Hode, PhD will be attending one of the most significant investor conferences in San...

Immunophotonics CEO Lu Alleruzzo announced, along with Dr. Robert CG Martin II, M.D, PhD, PACS, who serves as the Principal...